Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups

Abstract

Sequencing studies have shed some light on the pathogenesis of progression from smouldering multiple myeloma (SMM) and symptomatic multiple myeloma (MM). Given the scarcity of smouldering samples, little data are available to determine which translational programmes are dysregulated and whether the mechanisms of progression are uniform across the main molecular subgroups. In this work, we investigated 223 SMM and 1348 MM samples from the University of Arkansas for Medical Sciences (UAMS) for which we had gene expression profiling (GEP). Patients were analysed by TC-7 subgroup for gene expression changes between SMM and MM. Among the commonly dysregulated genes in each subgroup, PHF19 and EZH2 highlight the importance of the PRC2.1 complex. We show that subgroup specific differences exist even at the SMM stage of disease with different biological features driving progression within each TC molecular subgroup. These data suggest that MMSET SMM has already transformed, but that the other precursor diseases are distinct clinical entities from their symptomatic counterpart.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Boyle, E. M., Rosenthal, A., Ghamlouch, H., Wang, Y., Farmer, P., Rutherford, M., Ashby, C., Bauer, M., Johnson, S. K., Wardell, C. P., Wang, Y., Hoering, A., Schinke, C., Thanendrarajan, S., Zangari, M., Barlogie, B., Dhodapkar, M. V., Davies, F. E., Morgan, G. J., … Walker, B. A. (2022). Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups. Leukemia, 36(2), 591–595. https://doi.org/10.1038/s41375-021-01379-y
ISSN
1476-5551
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Leukemia
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}